13-33060846-C-T

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_004795.4(KL):​c.1767C>T​(p.His589His) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.38 in 1,614,016 control chromosomes in the GnomAD database, including 122,702 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.31 ( 9096 hom., cov: 33)
Exomes 𝑓: 0.39 ( 113606 hom. )

Consequence

KL
NM_004795.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -0.708

Publications

46 publications found
Variant links:
Genes affected
KL (HGNC:6344): (klotho) This gene encodes a type-I membrane protein that is related to beta-glucosidases. Reduced production of this protein has been observed in patients with chronic renal failure (CRF), and this may be one of the factors underlying the degenerative processes (e.g., arteriosclerosis, osteoporosis, and skin atrophy) seen in CRF. Also, mutations within this protein have been associated with ageing and bone loss. [provided by RefSeq, Jul 2008]
KL Gene-Disease associations (from GenCC):
  • tumoral calcinosis, hyperphosphatemic, familial, 1
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • tumoral calcinosis, hyperphosphatemic, familial, 3
    Inheritance: AR, Unknown Classification: LIMITED Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 13-33060846-C-T is Benign according to our data. Variant chr13-33060846-C-T is described in ClinVar as Benign. ClinVar VariationId is 311698.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.708 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.451 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KLNM_004795.4 linkc.1767C>T p.His589His synonymous_variant Exon 4 of 5 ENST00000380099.4 NP_004786.2 Q9UEF7-1
KLXM_006719895.3 linkc.846C>T p.His282His synonymous_variant Exon 4 of 5 XP_006719958.1
KLXM_047430776.1 linkc.*167C>T 3_prime_UTR_variant Exon 4 of 4 XP_047286732.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KLENST00000380099.4 linkc.1767C>T p.His589His synonymous_variant Exon 4 of 5 1 NM_004795.4 ENSP00000369442.3 Q9UEF7-1
KLENST00000487852.1 linkn.1825C>T non_coding_transcript_exon_variant Exon 4 of 5 5

Frequencies

GnomAD3 genomes
AF:
0.311
AC:
47244
AN:
152056
Hom.:
9085
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0899
Gnomad AMI
AF:
0.408
Gnomad AMR
AF:
0.459
Gnomad ASJ
AF:
0.426
Gnomad EAS
AF:
0.170
Gnomad SAS
AF:
0.316
Gnomad FIN
AF:
0.380
Gnomad MID
AF:
0.427
Gnomad NFE
AF:
0.403
Gnomad OTH
AF:
0.346
GnomAD2 exomes
AF:
0.375
AC:
94398
AN:
251476
AF XY:
0.375
show subpopulations
Gnomad AFR exome
AF:
0.0792
Gnomad AMR exome
AF:
0.542
Gnomad ASJ exome
AF:
0.429
Gnomad EAS exome
AF:
0.155
Gnomad FIN exome
AF:
0.377
Gnomad NFE exome
AF:
0.405
Gnomad OTH exome
AF:
0.402
GnomAD4 exome
AF:
0.388
AC:
566661
AN:
1461842
Hom.:
113606
Cov.:
58
AF XY:
0.387
AC XY:
281682
AN XY:
727222
show subpopulations
African (AFR)
AF:
0.0800
AC:
2677
AN:
33480
American (AMR)
AF:
0.537
AC:
24023
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.428
AC:
11194
AN:
26136
East Asian (EAS)
AF:
0.166
AC:
6604
AN:
39700
South Asian (SAS)
AF:
0.344
AC:
29668
AN:
86258
European-Finnish (FIN)
AF:
0.383
AC:
20470
AN:
53420
Middle Eastern (MID)
AF:
0.400
AC:
2307
AN:
5768
European-Non Finnish (NFE)
AF:
0.403
AC:
447579
AN:
1111962
Other (OTH)
AF:
0.367
AC:
22139
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
21836
43672
65507
87343
109179
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
13666
27332
40998
54664
68330
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.311
AC:
47265
AN:
152174
Hom.:
9096
Cov.:
33
AF XY:
0.310
AC XY:
23066
AN XY:
74406
show subpopulations
African (AFR)
AF:
0.0897
AC:
3726
AN:
41546
American (AMR)
AF:
0.460
AC:
7030
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.426
AC:
1479
AN:
3472
East Asian (EAS)
AF:
0.169
AC:
874
AN:
5162
South Asian (SAS)
AF:
0.315
AC:
1519
AN:
4824
European-Finnish (FIN)
AF:
0.380
AC:
4021
AN:
10578
Middle Eastern (MID)
AF:
0.425
AC:
125
AN:
294
European-Non Finnish (NFE)
AF:
0.403
AC:
27381
AN:
67982
Other (OTH)
AF:
0.350
AC:
739
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1538
3075
4613
6150
7688
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
462
924
1386
1848
2310
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.343
Hom.:
4998
Bravo
AF:
0.310
Asia WGS
AF:
0.274
AC:
955
AN:
3478
EpiCase
AF:
0.408
EpiControl
AF:
0.404

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Tumoral calcinosis, hyperphosphatemic, familial, 3 Benign:2
Aug 19, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
0.63
DANN
Benign
0.31
PhyloP100
-0.71
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs564481; hg19: chr13-33634983; COSMIC: COSV66308637; API